AZACITIDINE
azacitidine 100 mg injection, 1 vial
AZACITIDINE (13028Q)
13028Q
Manner of administration:Injection
Restriction
Indication: Myelodysplastic syndrome
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 14 | Max qty units: 14 | # of repeats: 5 | DPMQ: $204.82 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||